
Christopher John DiMaio MD
Advanced Endoscopic Interventional, Biliary Tract Disease, Gastrointestinal Cancer, Pancreas Disease
Regional Director of Endoscopy Northwell Health Physician Partners Gastroenterology
Join to View Full Profile
284 Pulaski Rd2nd FloorGreenlawn, NY 11740
Phone+1 516-788-3246
Fax+1 631-470-1458
Dr. DiMaio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2008
- Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 2008
- NYP Hosp-Columbia Univ Med Ctr2007
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2000 - 2003
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 2000 - 2001
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
- NY State Medical License 2004 - 2026
- PA State Medical License 2001 - 2004
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Endoscopic Ultrasound in Gastric Cancer.Isaiah P Schuster, Christopher J DiMaio
The Surgical Clinics of North America. 2025-02-01 - 14 citationsSnare Tip Soft Coagulation vs Argon Plasma Coagulation vs No Margin Treatment After Large Nonpedunculated Colorectal Polyp Resection: a Randomized Trial.Douglas K Rex, Gregory B Haber, Mouen Khashab, Amit Rastogi, Muhammad K Hasan
Clinical Gastroenterology and Hepatology. 2024-03-01 - 2 citationsFrequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants.Aimee L Lucas, Yichun Fu, Arielle J Labiner, Christopher J Dimaio, Amrita Sethi
Clinical Gastroenterology and Hepatology. 2023-09-01
Press Mentions
- Dose-Escalation of Second-Line and First-Line Asciminib in Chronic Myeloid Leukemia in Chronic Phase: The ASC2ESCALATE Phase II TrialOctober 10th, 2024
- 7 GI Expansions and New Centers in the Last 30 DaysFebruary 9th, 2022
- Catholic Health's Gastroenterology Chair Building Endoscopy Center of ExcellenceJanuary 21st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: